Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
Type:
Grant
Filed:
May 6, 2003
Date of Patent:
October 24, 2006
Assignee:
Janssen Pharmaceutica
Inventors:
Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill, Lan Shen, Keith Demarest, Bruce R. Conway, David F. McComsey